Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies

1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167–1173. 10209995

2. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835–1846. doi: 10.1016/S0140-6736(11)61904-1 22494827

3. Lijfering WM, Rosendaal FR, Cannegieter SC. Risk factors for venous thrombosis—current understanding from an epidemiological point of view. Br J Haematol. 2010;149:824–833. doi: 10.1111/j.1365-2141.2010.08206.x 20456358

4. Hippisley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656. doi: 10.1136/bmj.d4656 21846713

5. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8:2450–2457. doi: 10.1111/j.1538-7836.2010.04044.x 20738765

6. de Haan HG, Bezemer ID, Doggen CJ, Le Cessie S, Reitsma PH, Arellano AR, et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood. 2012;120:656–663. doi: 10.1182/blood-2011-12-397752 22586183

7. Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, Drach J, et al. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2009;27:4124–4129. doi: 10.1200/JCO.2008.21.7752 19636003

8. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111:4902–4907. doi: 10.1182/blood-2007-10-116327 18216292

9. Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C, et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol. 2009;29:2176–2181. doi: 10.1161/ATVBAHA.109.190827 19778945

10. van Adrichem RA, Debeij J, Nelissen RG, Schipper IB, Rosendaal FR, Cannegieter SC. Below-knee cast immobilization and the risk of venous thrombosis: results from a large population-based case–control study. J Thromb Haemost. 2014;12:1461–1469. doi: 10.1111/jth.12655 25040873

11. Ettema HB, Kollen BJ, Verheyen CC, Buller HR. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2008;6:1093–1098. doi: 10.1111/j.1538-7836.2008.02984.x 18429944

12. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e278S–e325S. doi: 10.1378/chest.11-2404 22315265

13. Testroote M, Stigter W, de Visser DC, Janzing H. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. Cochrane Database Syst Rev. 2008;2008:CD006681.

14. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715–722. 15701913

15. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med. 2007;167:497–501. 17353498

16. Cannegieter SC, Doggen CJ, van Houwelingen HC, Rosendaal FR. Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med. 2006;3:e307. 16933962

17. Gomez E, van der Poel SC, Jansen JH, van der Reijden BA, Lowenberg B. Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood. Blood. 1998;91:2208–2209. 9490710

18. Ocak G, Vossen CY, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC, et al. Risk of venous thrombosis in patients with major illnesses: results from the MEGA study. J Thromb Haemost. 2013;11:116–123. doi: 10.1111/jth.12043 23106832

19. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18:681–694. 10204197

20. Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691–698. doi: 10.1136/heartjnl-2011-301247 22397946

21. van Hylckama Vlieg A (2009) Thrombophilia, hypercoagulability, and environment, and the risk of venous thrombo-embolism (THE-VTE study) [abstract]. Abstract number 7:PP-MO-289. XXII Congress of the International Society on Thrombosis and Haemostasis; 11–16 July 2009; Boston, MA, US.

22. van Hylckama Vlieg A, Baglin CA, Luddington R, MacDonald S, Rosendaal FR, Baglin TP. The risk of a first and recurrent venous thrombosis associated with elevated D-dimer and thrombin potential; results of THE-VTE Study. J Thromb Haemost. 2015;13:1642–1652. doi: 10.1111/jth.13043 26178257

23. Ribeiro DD, Bucciarelli P, Braekkan SK, Lijfering WM, Passamonti SM, Brodin EE, et al. Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromso. J Thromb Haemost. 2012;10:1704–1707. doi: 10.1111/j.1538-7836.2012.04811.x 22681473

24. Nokes TJ, Keenan J. Thromboprophylaxis in patients with lower limb immobilisation—review of current status. Br J Haematol. 2009;146:361–368. doi: 10.1111/j.1365-2141.2009.07737.x 19519693

25. Struijk-Mulder MC, Ettema HB, Verheyen CC, Buller HR. Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J Thromb Haemost. 2010;8:678–683. doi: 10.1111/j.1538-7836.2009.03728.x 20040041

26. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160:3415–3420. 11112234

27. Kamphuisen PW, Eikenboom JC, Vos HL, Pablo R, Sturk A, Bertina RM, et al. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost. 1999;81:680–683. 10365736

28. Kraaijenhagen RA, in’t Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83:5–9. 10669145

29. O’Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost. 2000;83:10–13. 10669146

30. Truijers M, Kranendonk SE, Nurmohamed MT. [Thromboprophylaxis in general surgical practices in the year 2004: perioperative use during hospitalisation, during out-patient care and following plaster cast immobilisation.] Ned Tijdschr Geneeskd. 2005;149:2511–2516. 16304889

31. National Institute for Health Care and Excellence. Venous thromboembolism in adults admitted to hospital: reducing the risk. NICE guidelines [CG92]. London: National Institute for Health Care and Excellence; 2010.

32. Baglin T, Barrowcliffe TW, Cohen A, Greaves M. Guidelines on the use and monitoring of heparin. Br J Haematol. 2006;133:19–34. 16512825

33. Kearon C, Iorio A, Palareti G. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost. 2010;8:2313–2315. doi: 10.1111/j.1538-7836.2010.03991.x 20738761